EUVIMEDEUVIMED entdecken
Open Access

Admission Gut and Plasma‐Derived Signatures Associated With Severity and 90‐day Outcome in Hepatitis A–Related and Drug‐Induced Acute Liver Failure

Anoushka Saxena iD, Rakhi Maiwall iD, Babu Lal Meena iD, Jaswinder Singh Maras iD, Varun Suroliya iD, Guresh Kumar, Shiv K Sarin iD, Nirupama Trehanpati iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.71150 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Anoushka Saxena und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India. Hauptthemen laut MEDLINE: Liver Failure, Acute, Hepatitis A, Gastrointestinal Microbiome, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute liver failure (ALF) due to hepatitis A (ALF‐A) has high mortality, but admission‐day markers associated with disease severity and outcome are unknown. We aimed to define gut microbiome and plasma multi‐omics signatures associated with severity and 90‐day outcomes in ALF‐A, compared to drug‐induced ALF (ALF‐D) as non‐viral ALF group. ALF patients (aged 26 ± 9 years; 50.7% male, 49.3% female) with IgM HAV positive (ALF‐A, n = 33), ALF‐D ( n = 38) were recruited along with acute viral hepatitis (AVH‐A, n = 27) and healthy subjects (HC, n = 20). Stool bacteria profiling was done at D0; plasma cytokines, metabolites and barrier markers were analysed at D0, 3, 5, 7. Correlations with clinical severity parameters were assessed. Associations with 90‐day mortality were assessed using severity‐adjusted association analyses. ALF‐A patients were more severe at the time of admission than ALF‐D. In ALF–A, 90‐day mortality was 33% versus 18.4% with increased severity scores like KCH 21% versus 10.5%, SOFA score 7.97 ± 2.89 versus 5.87 ± 2.32, SIRS 60.6% versus 18.4%, mechanical ventilation 39% versus 21%. At D0, ALF‐A was enriched for lactate/ammonia/bile salt hydrolase/histamine‐producing pathobionts like Enterococcus, Ruminococcus gnavus, Flavonifractor, Thomasclavelia correlating positively with severity (|r| > 0.4, p < 0.05) showing higher baseline abundance in ALF‐A non‐survivors (NS). At D0 in ALF‐A, histamine accumulation, reduced tryptophan, butyrate metabolism inversely correlated with severity and worsened in ALF‐A_NS by D7. Pro‐inflammatory cytokines, IFABP2 were elevated at Day 0 in ALF‐A, correlated positively with severity, and remained increased through Day 7 in ALF‐A_NS. In contrast, ALF‐D_NS retained commensals, showed increased fatty acid, bile acid biosynthesis with low levels of pro‐inflammatory cytokines. In ALF‐A, gut and plasma integrated multi‐omics features were associated with disease severity, 90‐day outcomes and identified candidate biomarkers for future validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver Failure, AcuteHepatitis AGastrointestinal MicrobiomeChemical and Drug Induced Liver InjuryHumansFemaleMaleAdultSeverity of Illness IndexBiomarkersFecesCytokinesYoung AdultMultiomics

Stichwörter der Autor:innen

Hepatitis Adrug‐induced liver injuryliver failure, acutemetabolomicsmicrobiome

Substanzen

BiomarkersCytokines

Autor:innen und Institutionen

  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Genome Sequencing Lab, Institute of Liver and Biliary Sciences, New Delhi, India.
  • Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, Facility of Biostatistics, New Delhi, India.

ORCID-Profile: Anoushka Saxena, Rakhi Maiwall, Babu Lal Meena, Jaswinder Singh Maras, Varun Suroliya, Shiv K Sarin, Nirupama Trehanpati

Förderung

  • Indian Council of Medical Research

Zitieren

APA

Saxena, A., Maiwall, R., Meena, B. L., Maras, J. S., Suroliya, V., Kumar, G., Sarin, S. K., & Trehanpati, N. (2026). Admission Gut and Plasma‐Derived Signatures Associated With Severity and 90‐day Outcome in Hepatitis A–Related and Drug‐Induced Acute Liver Failure. Journal of Medical Virology. https://doi.org/10.1002/jmv.71150

Vancouver

Saxena A, Maiwall R, Meena BL, Maras JS, Suroliya V, Kumar G, et al. Admission Gut and Plasma‐Derived Signatures Associated With Severity and 90‐day Outcome in Hepatitis A–Related and Drug‐Induced Acute Liver Failure. Journal of Medical Virology. 2026. doi:10.1002/jmv.71150

BibTeX
@article{Saxena2026,
  author = {Saxena, Anoushka and Maiwall, Rakhi and Meena, Babu Lal and Maras, Jaswinder Singh and Suroliya, Varun and Kumar, Guresh and Sarin, Shiv K and Trehanpati, Nirupama},
  title = {Admission Gut and Plasma‐Derived Signatures Associated With Severity and 90‐day Outcome in Hepatitis A–Related and Drug‐Induced Acute Liver Failure},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.71150}
}
Kostenlos starten →